We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+2.86%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$14.5B
AUM Growth
+$59.6M
Cap. Flow
-$238M
Cap. Flow %
-1.65%
Top 10 Hldgs %
15.54%
Holding
2,654
New
131
Increased
878
Reduced
781
Closed
88

Sector Composition

Rank Sector Weight
1 Financials 14.52%
2 Technology 14.04%
3 Healthcare 11.73%
4 Industrials 10.12%
5 Consumer Discretionary 8.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SFST icon
2376
Southern First Bancshares
SFST
$610M
$184K ﹤0.01%
+4,958
New +$170K
DGII icon
2377
Digi International
DGII
$3.23B
$183K ﹤0.01%
18,076
FBK icon
2378
FB Financial Corp
FBK
$3.1B
$183K ﹤0.01%
5,058
AXAS
2379
DELISTED
Abraxas Petroleum Corp
AXAS
$183K ﹤0.01%
5,651
+396
+8% +$14.9K
LTS
2380
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
$183K ﹤0.01%
74,856
BLMT
2381
DELISTED
BSB Bancorp, Inc.
BLMT
$183K ﹤0.01%
6,273
BGFV
2382
DELISTED
Big 5 Sporting Goods
BGFV
$182K ﹤0.01%
13,956
LCTX icon
2383
Lineage Cell Therapeutics
LCTX
$271M
$182K ﹤0.01%
65,944
LE icon
2384
Lands' End
LE
$388M
$182K ﹤0.01%
12,231
VATE icon
2385
INNOVATE Corp
VATE
$104M
$182K ﹤0.01%
+3,094
New +$178K
SMMF
2386
DELISTED
Summit Financial Group, Inc.
SMMF
$182K ﹤0.01%
+8,272
New +$181K
ECOM
2387
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$182K ﹤0.01%
15,726
ADMS
2388
DELISTED
Adamas Pharmaceuticals
ADMS
$182K ﹤0.01%
10,428
MRVL icon
2389
Marvell Technology
MRVL
$204B
$181K ﹤0.01%
10,977
-552
-5% -$8.93K
CNCE
2390
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$181K ﹤0.01%
+12,976
New +$191K
FARM
2391
DELISTED
Farmer Brothers
FARM
$180K ﹤0.01%
5,938
IBRX icon
2392
ImmunityBio
IBRX
$8.14B
$180K ﹤0.01%
+23,692
New +$102K
VIVS
2393
VivoSim Labs
VIVS
$1.15M
$180K ﹤0.01%
285
CIVI
2394
DELISTED
Civitas Solutions, Inc.
CIVI
$180K ﹤0.01%
10,292
PFSI icon
2395
PennyMac Financial
PFSI
$4.14B
$179K ﹤0.01%
10,699
CHUBA
2396
DELISTED
CommerceHub, Inc. Series A Common Stock
CHUBA
$179K ﹤0.01%
10,258
+9,778
+2,037% +$161K
LXU icon
2397
LSB Industries
LXU
$706M
$178K ﹤0.01%
+22,404
New +$159K
ZUMZ icon
2398
Zumiez
ZUMZ
$321M
$178K ﹤0.01%
14,431
FBMS
2399
DELISTED
The First Bancshares, Inc.
FBMS
$178K ﹤0.01%
+6,458
New +$181K
ZAGG
2400
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
$178K ﹤0.01%
+20,562
New +$164K

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q2 2017 Portfolio in Review

As of Q2 2017, Metropolitan Life Insurance Company (MetLife) held 2,654 positions worth $14.5B, up 0.41% from $14.4B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q2 2017 filing shows 131 new, 878 increased, 781 reduced and 88 closed positions. Its largest new stake was DXC Technology: 172,294 shares worth $11.4M. The largest sale was Yahoo Inc, an estimated $20.3M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q2 2017 buy was DXC Technology: 172,294 shares worth $11.4M.
  • Metropolitan Life Insurance Company (MetLife) added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2017, an estimated $64.3M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q2 2017 reduction was Apple, cutting an estimated $9.01M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Yahoo Inc in Q2 2017, selling an estimated $20.3M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 16% of its $14.5B portfolio in Q2 2017.
  • Metropolitan Life Insurance Company (MetLife) opened 131 new positions and closed 88 in Q2 2017.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 0.41% quarter-over-quarter to $14.5B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2017, filed 14 Aug 2017.